Patients won't participate in a clinical trial if it's too much of a burden, so we have to bring the trials to where the patients live, explained Katie Goodman, RN, BSN, CCRP, director of clinical research, Florida Cancer Specialists & Research Institute.
Patients won't participate in a clinical trial if it's too much of a burden, so we have to bring the trials to where the patients live, explained Katie Goodman, RN, BSN, CCRP, director of clinical research, Florida Cancer Specialists & Research Institute.
Transcript
How is community oncology poised to shape the future of cancer care in regard to clinical trials?
Community oncology practices are where most patients receive their treatment. So, if we need patients to participate in clinical trials to get the answers, to move the needle on the science, to know whether or not this next treatment is effective of not, we have to bring the trials to where those patients are being treated. We also know that patients aren’t going to participate in a clinical trial if it’s too much burden on them. So, they have to travel great distances in order to participate. Cancer patients are usually in the clinic once a week at the very least, if not more, and that is too great a burden on a patient. We want the answers, we want the science, and the only way we can really do that is to bring the trials to the patients where they live. So, it is very important to us in the practice that I work at that we continue to offer clinical trials in the community setting.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More